InVentiv Will Redeploy Sanofi-Aventis Reps To Santarus By Year End
This article was originally published in The Pink Sheet Daily
Executive Summary
Recent acquisitions and contract shifts have broadened the contract sales organization’s revenue base, minimizing loss of Allegra contract, inVentiv CEO Broshy says.
You may also be interested in...
Alliant To Detail Allegra Oral Suspension
The two-year contract covers U.S. pediatricians and pediatric sub-specialties.
Alliant To Detail Allegra Oral Suspension
The two-year contract covers U.S. pediatricians and pediatric sub-specialties.
Sanofi-Aventis Ends PDI Sales Contract
Big pharma is “reevaluating its commercial model,” PDI said in reaction to losing the $18 mil. to $20 mil. Sanofi contract.